Global Tumor Early Screening Products Supply, Demand and Key Producers, 2023-2029

Description

The global Tumor Early Screening Products market size is expected to reach $ 1473 million by 2029, rising at a market growth of 11.9% CAGR during the forecast period (2023-2029).

The market for tumor early screening products is rapidly evolving and expanding. With increasing awareness of the importance of early detection and advances in medical technology, there is a growing demand for effective screening tools to detect tumors at the earliest stages. The market size for these products is projected to be substantial and is expected to experience significant growth in the coming years. As research and development efforts continue, innovative technologies such as liquid biopsies, genomic testing, and artificial intelligence-based algorithms are being incorporated into tumor screening products, enhancing their accuracy and efficiency. Additionally, the integration of telemedicine and remote monitoring solutions is further driving the market's growth, enabling easier access to screening services for individuals in remote areas. The future development of tumor early screening products holds promising prospects, with a focus on improving sensitivity, specificity, and cost-effectiveness. These advancements have the potential to revolutionize cancer care by enabling early detection, leading to better treatment outcomes and improved survival rates.

Tumor Early Screening Products refer to products for screening for early cancer and precancerous lesions for target populations who are apparently healthy and have not yet shown obvious abnormal symptoms
This report studies the global Tumor Early Screening Products demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Tumor Early Screening Products, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor Early Screening Products that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Tumor Early Screening Products total market, 2018-2029, (USD Million)
Global Tumor Early Screening Products total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Tumor Early Screening Products total market, key domestic companies and share, (USD Million)
Global Tumor Early Screening Products revenue by player and market share 2018-2023, (USD Million)
Global Tumor Early Screening Products total market by Type, CAGR, 2018-2029, (USD Million)
Global Tumor Early Screening Products total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Tumor Early Screening Products market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, MBMbio and Oncognostic, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor Early Screening Products market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Tumor Early Screening Products Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Tumor Early Screening Products Market, Segmentation by Type
    Liver Cancer
    Colorectal Cancer
    Lung Cancer
    Other

Global Tumor Early Screening Products Market, Segmentation by Application
    Hospital
    Medical Center
    Other

Companies Profiled:
    Exact Sciences
    Grail
    Genetron Health
    New Horizon Health
    Burning Rock
    Berry Oncology
    Shanghai Kunyuan Biotechnology
    MBMbio
    Oncognostic
    Epigenomics
    Guardant Health
    Freenome
    Abbott
    iStat Biomedical

Key Questions Answered
1. How big is the global Tumor Early Screening Products market?
2. What is the demand of the global Tumor Early Screening Products market?
3. What is the year over year growth of the global Tumor Early Screening Products market?
4. What is the total value of the global Tumor Early Screening Products market?
5. Who are the major players in the global Tumor Early Screening Products market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Tumor Early Screening Products Introduction
    1.2 World Tumor Early Screening Products Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Tumor Early Screening Products Total Market by Region (by Headquarter Location)
        1.3.1 World Tumor Early Screening Products Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Tumor Early Screening Products Market Size (2018-2029)
        1.3.3 China Tumor Early Screening Products Market Size (2018-2029)
        1.3.4 Europe Tumor Early Screening Products Market Size (2018-2029)
        1.3.5 Japan Tumor Early Screening Products Market Size (2018-2029)
        1.3.6 South Korea Tumor Early Screening Products Market Size (2018-2029)
        1.3.7 ASEAN Tumor Early Screening Products Market Size (2018-2029)
        1.3.8 India Tumor Early Screening Products Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Tumor Early Screening Products Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Tumor Early Screening Products Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Tumor Early Screening Products Consumption Value (2018-2029)
    2.2 World Tumor Early Screening Products Consumption Value by Region
        2.2.1 World Tumor Early Screening Products Consumption Value by Region (2018-2023)
        2.2.2 World Tumor Early Screening Products Consumption Value Forecast by Region (2024-2029)
    2.3 United States Tumor Early Screening Products Consumption Value (2018-2029)
    2.4 China Tumor Early Screening Products Consumption Value (2018-2029)
    2.5 Europe Tumor Early Screening Products Consumption Value (2018-2029)
    2.6 Japan Tumor Early Screening Products Consumption Value (2018-2029)
    2.7 South Korea Tumor Early Screening Products Consumption Value (2018-2029)
    2.8 ASEAN Tumor Early Screening Products Consumption Value (2018-2029)
    2.9 India Tumor Early Screening Products Consumption Value (2018-2029)

3 World Tumor Early Screening Products Companies Competitive Analysis
    3.1 World Tumor Early Screening Products Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Tumor Early Screening Products Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Tumor Early Screening Products in 2022
        3.2.3 Global Concentration Ratios (CR8) for Tumor Early Screening Products in 2022
    3.3 Tumor Early Screening Products Company Evaluation Quadrant
    3.4 Tumor Early Screening Products Market: Overall Company Footprint Analysis
        3.4.1 Tumor Early Screening Products Market: Region Footprint
        3.4.2 Tumor Early Screening Products Market: Company Product Type Footprint
        3.4.3 Tumor Early Screening Products Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Tumor Early Screening Products Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Tumor Early Screening Products Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Tumor Early Screening Products Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Tumor Early Screening Products Consumption Value Comparison
        4.2.1 United States VS China: Tumor Early Screening Products Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Tumor Early Screening Products Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Tumor Early Screening Products Companies and Market Share, 2018-2023
        4.3.1 United States Based Tumor Early Screening Products Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Tumor Early Screening Products Revenue, (2018-2023)
    4.4 China Based Companies Tumor Early Screening Products Revenue and Market Share, 2018-2023
        4.4.1 China Based Tumor Early Screening Products Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Tumor Early Screening Products Revenue, (2018-2023)
    4.5 Rest of World Based Tumor Early Screening Products Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Tumor Early Screening Products Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Tumor Early Screening Products Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Tumor Early Screening Products Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Liver Cancer
        5.2.2 Colorectal Cancer
        5.2.3 Lung Cancer
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Tumor Early Screening Products Market Size by Type (2018-2023)
        5.3.2 World Tumor Early Screening Products Market Size by Type (2024-2029)
        5.3.3 World Tumor Early Screening Products Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Tumor Early Screening Products Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Medical Center
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Tumor Early Screening Products Market Size by Application (2018-2023)
        6.3.2 World Tumor Early Screening Products Market Size by Application (2024-2029)
        6.3.3 World Tumor Early Screening Products Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Exact Sciences
        7.1.1 Exact Sciences Details
        7.1.2 Exact Sciences Major Business
        7.1.3 Exact Sciences Tumor Early Screening Products Product and Services
        7.1.4 Exact Sciences Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Exact Sciences Recent Developments/Updates
        7.1.6 Exact Sciences Competitive Strengths & Weaknesses
    7.2 Grail
        7.2.1 Grail Details
        7.2.2 Grail Major Business
        7.2.3 Grail Tumor Early Screening Products Product and Services
        7.2.4 Grail Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Grail Recent Developments/Updates
        7.2.6 Grail Competitive Strengths & Weaknesses
    7.3 Genetron Health
        7.3.1 Genetron Health Details
        7.3.2 Genetron Health Major Business
        7.3.3 Genetron Health Tumor Early Screening Products Product and Services
        7.3.4 Genetron Health Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Genetron Health Recent Developments/Updates
        7.3.6 Genetron Health Competitive Strengths & Weaknesses
    7.4 New Horizon Health
        7.4.1 New Horizon Health Details
        7.4.2 New Horizon Health Major Business
        7.4.3 New Horizon Health Tumor Early Screening Products Product and Services
        7.4.4 New Horizon Health Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 New Horizon Health Recent Developments/Updates
        7.4.6 New Horizon Health Competitive Strengths & Weaknesses
    7.5 Burning Rock
        7.5.1 Burning Rock Details
        7.5.2 Burning Rock Major Business
        7.5.3 Burning Rock Tumor Early Screening Products Product and Services
        7.5.4 Burning Rock Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Burning Rock Recent Developments/Updates
        7.5.6 Burning Rock Competitive Strengths & Weaknesses
    7.6 Berry Oncology
        7.6.1 Berry Oncology Details
        7.6.2 Berry Oncology Major Business
        7.6.3 Berry Oncology Tumor Early Screening Products Product and Services
        7.6.4 Berry Oncology Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Berry Oncology Recent Developments/Updates
        7.6.6 Berry Oncology Competitive Strengths & Weaknesses
    7.7 Shanghai Kunyuan Biotechnology
        7.7.1 Shanghai Kunyuan Biotechnology Details
        7.7.2 Shanghai Kunyuan Biotechnology Major Business
        7.7.3 Shanghai Kunyuan Biotechnology Tumor Early Screening Products Product and Services
        7.7.4 Shanghai Kunyuan Biotechnology Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Shanghai Kunyuan Biotechnology Recent Developments/Updates
        7.7.6 Shanghai Kunyuan Biotechnology Competitive Strengths & Weaknesses
    7.8 MBMbio
        7.8.1 MBMbio Details
        7.8.2 MBMbio Major Business
        7.8.3 MBMbio Tumor Early Screening Products Product and Services
        7.8.4 MBMbio Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 MBMbio Recent Developments/Updates
        7.8.6 MBMbio Competitive Strengths & Weaknesses
    7.9 Oncognostic
        7.9.1 Oncognostic Details
        7.9.2 Oncognostic Major Business
        7.9.3 Oncognostic Tumor Early Screening Products Product and Services
        7.9.4 Oncognostic Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Oncognostic Recent Developments/Updates
        7.9.6 Oncognostic Competitive Strengths & Weaknesses
    7.10 Epigenomics
        7.10.1 Epigenomics Details
        7.10.2 Epigenomics Major Business
        7.10.3 Epigenomics Tumor Early Screening Products Product and Services
        7.10.4 Epigenomics Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Epigenomics Recent Developments/Updates
        7.10.6 Epigenomics Competitive Strengths & Weaknesses
    7.11 Guardant Health
        7.11.1 Guardant Health Details
        7.11.2 Guardant Health Major Business
        7.11.3 Guardant Health Tumor Early Screening Products Product and Services
        7.11.4 Guardant Health Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Guardant Health Recent Developments/Updates
        7.11.6 Guardant Health Competitive Strengths & Weaknesses
    7.12 Freenome
        7.12.1 Freenome Details
        7.12.2 Freenome Major Business
        7.12.3 Freenome Tumor Early Screening Products Product and Services
        7.12.4 Freenome Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Freenome Recent Developments/Updates
        7.12.6 Freenome Competitive Strengths & Weaknesses
    7.13 Abbott
        7.13.1 Abbott Details
        7.13.2 Abbott Major Business
        7.13.3 Abbott Tumor Early Screening Products Product and Services
        7.13.4 Abbott Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Abbott Recent Developments/Updates
        7.13.6 Abbott Competitive Strengths & Weaknesses
    7.14 iStat Biomedical
        7.14.1 iStat Biomedical Details
        7.14.2 iStat Biomedical Major Business
        7.14.3 iStat Biomedical Tumor Early Screening Products Product and Services
        7.14.4 iStat Biomedical Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 iStat Biomedical Recent Developments/Updates
        7.14.6 iStat Biomedical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Tumor Early Screening Products Industry Chain
    8.2 Tumor Early Screening Products Upstream Analysis
    8.3 Tumor Early Screening Products Midstream Analysis
    8.4 Tumor Early Screening Products Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Tumor Early Screening Products Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Tumor Early Screening Products Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Tumor Early Screening Products Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Tumor Early Screening Products Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Tumor Early Screening Products Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Tumor Early Screening Products Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Tumor Early Screening Products Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Tumor Early Screening Products Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Tumor Early Screening Products Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Tumor Early Screening Products Players in 2022
    Table 12. World Tumor Early Screening Products Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Tumor Early Screening Products Company Evaluation Quadrant
    Table 14. Head Office of Key Tumor Early Screening Products Player
    Table 15. Tumor Early Screening Products Market: Company Product Type Footprint
    Table 16. Tumor Early Screening Products Market: Company Product Application Footprint
    Table 17. Tumor Early Screening Products Mergers & Acquisitions Activity
    Table 18. United States VS China Tumor Early Screening Products Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Tumor Early Screening Products Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Tumor Early Screening Products Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Tumor Early Screening Products Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Tumor Early Screening Products Revenue Market Share (2018-2023)
    Table 23. China Based Tumor Early Screening Products Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Tumor Early Screening Products Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Tumor Early Screening Products Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Tumor Early Screening Products Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Tumor Early Screening Products Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Tumor Early Screening Products Revenue Market Share (2018-2023)
    Table 29. World Tumor Early Screening Products Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Tumor Early Screening Products Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Tumor Early Screening Products Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Tumor Early Screening Products Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Tumor Early Screening Products Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Tumor Early Screening Products Market Size by Application (2024-2029) & (USD Million)
    Table 35. Exact Sciences Basic Information, Area Served and Competitors
    Table 36. Exact Sciences Major Business
    Table 37. Exact Sciences Tumor Early Screening Products Product and Services
    Table 38. Exact Sciences Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Exact Sciences Recent Developments/Updates
    Table 40. Exact Sciences Competitive Strengths & Weaknesses
    Table 41. Grail Basic Information, Area Served and Competitors
    Table 42. Grail Major Business
    Table 43. Grail Tumor Early Screening Products Product and Services
    Table 44. Grail Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Grail Recent Developments/Updates
    Table 46. Grail Competitive Strengths & Weaknesses
    Table 47. Genetron Health Basic Information, Area Served and Competitors
    Table 48. Genetron Health Major Business
    Table 49. Genetron Health Tumor Early Screening Products Product and Services
    Table 50. Genetron Health Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Genetron Health Recent Developments/Updates
    Table 52. Genetron Health Competitive Strengths & Weaknesses
    Table 53. New Horizon Health Basic Information, Area Served and Competitors
    Table 54. New Horizon Health Major Business
    Table 55. New Horizon Health Tumor Early Screening Products Product and Services
    Table 56. New Horizon Health Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. New Horizon Health Recent Developments/Updates
    Table 58. New Horizon Health Competitive Strengths & Weaknesses
    Table 59. Burning Rock Basic Information, Area Served and Competitors
    Table 60. Burning Rock Major Business
    Table 61. Burning Rock Tumor Early Screening Products Product and Services
    Table 62. Burning Rock Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Burning Rock Recent Developments/Updates
    Table 64. Burning Rock Competitive Strengths & Weaknesses
    Table 65. Berry Oncology Basic Information, Area Served and Competitors
    Table 66. Berry Oncology Major Business
    Table 67. Berry Oncology Tumor Early Screening Products Product and Services
    Table 68. Berry Oncology Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Berry Oncology Recent Developments/Updates
    Table 70. Berry Oncology Competitive Strengths & Weaknesses
    Table 71. Shanghai Kunyuan Biotechnology Basic Information, Area Served and Competitors
    Table 72. Shanghai Kunyuan Biotechnology Major Business
    Table 73. Shanghai Kunyuan Biotechnology Tumor Early Screening Products Product and Services
    Table 74. Shanghai Kunyuan Biotechnology Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Shanghai Kunyuan Biotechnology Recent Developments/Updates
    Table 76. Shanghai Kunyuan Biotechnology Competitive Strengths & Weaknesses
    Table 77. MBMbio Basic Information, Area Served and Competitors
    Table 78. MBMbio Major Business
    Table 79. MBMbio Tumor Early Screening Products Product and Services
    Table 80. MBMbio Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. MBMbio Recent Developments/Updates
    Table 82. MBMbio Competitive Strengths & Weaknesses
    Table 83. Oncognostic Basic Information, Area Served and Competitors
    Table 84. Oncognostic Major Business
    Table 85. Oncognostic Tumor Early Screening Products Product and Services
    Table 86. Oncognostic Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Oncognostic Recent Developments/Updates
    Table 88. Oncognostic Competitive Strengths & Weaknesses
    Table 89. Epigenomics Basic Information, Area Served and Competitors
    Table 90. Epigenomics Major Business
    Table 91. Epigenomics Tumor Early Screening Products Product and Services
    Table 92. Epigenomics Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Epigenomics Recent Developments/Updates
    Table 94. Epigenomics Competitive Strengths & Weaknesses
    Table 95. Guardant Health Basic Information, Area Served and Competitors
    Table 96. Guardant Health Major Business
    Table 97. Guardant Health Tumor Early Screening Products Product and Services
    Table 98. Guardant Health Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Guardant Health Recent Developments/Updates
    Table 100. Guardant Health Competitive Strengths & Weaknesses
    Table 101. Freenome Basic Information, Area Served and Competitors
    Table 102. Freenome Major Business
    Table 103. Freenome Tumor Early Screening Products Product and Services
    Table 104. Freenome Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Freenome Recent Developments/Updates
    Table 106. Freenome Competitive Strengths & Weaknesses
    Table 107. Abbott Basic Information, Area Served and Competitors
    Table 108. Abbott Major Business
    Table 109. Abbott Tumor Early Screening Products Product and Services
    Table 110. Abbott Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Abbott Recent Developments/Updates
    Table 112. iStat Biomedical Basic Information, Area Served and Competitors
    Table 113. iStat Biomedical Major Business
    Table 114. iStat Biomedical Tumor Early Screening Products Product and Services
    Table 115. iStat Biomedical Tumor Early Screening Products Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Tumor Early Screening Products Upstream (Raw Materials)
    Table 117. Tumor Early Screening Products Typical Customers
List of Figure
    Figure 1. Tumor Early Screening Products Picture
    Figure 2. World Tumor Early Screening Products Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Tumor Early Screening Products Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Tumor Early Screening Products Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Tumor Early Screening Products Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Tumor Early Screening Products Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Tumor Early Screening Products Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Tumor Early Screening Products Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Tumor Early Screening Products Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Tumor Early Screening Products Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Tumor Early Screening Products Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Tumor Early Screening Products Revenue (2018-2029) & (USD Million)
    Figure 13. Tumor Early Screening Products Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Tumor Early Screening Products Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Tumor Early Screening Products Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Tumor Early Screening Products by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor Early Screening Products Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor Early Screening Products Markets in 2022
    Figure 27. United States VS China: Tumor Early Screening Products Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Tumor Early Screening Products Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Tumor Early Screening Products Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Tumor Early Screening Products Market Size Market Share by Type in 2022
    Figure 31. Liver Cancer
    Figure 32. Colorectal Cancer
    Figure 33. Lung Cancer
    Figure 34. Other
    Figure 35. World Tumor Early Screening Products Market Size Market Share by Type (2018-2029)
    Figure 36. World Tumor Early Screening Products Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Tumor Early Screening Products Market Size Market Share by Application in 2022
    Figure 38. Hospital
    Figure 39. Medical Center
    Figure 40. Other
    Figure 41. Tumor Early Screening Products Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
MBMbio
Oncognostic
Epigenomics
Guardant Health
Freenome
Abbott
iStat Biomedical